Morgan Stanley Discount Zert REGN.../ DE000MG1BNF5 /
| 1/23/2025 8:54:21 PM | Chg.+0.82 | Bid10:00:37 PM | Ask10:00:37 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 66.70EUR | +1.24% | - Bid Size: - |
- Ask Size: - |
Regeneron Pharmaceut... | - USD | 3/28/2025 | Call |
Newsfile Corp
1/23
REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportun...
Newsfile Corp
1/23
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Coun...
Newsfile Corp
1/23
Securities Class Action Allegations Cast Shadow Over Regeneron Pharmaceuticals (REGN)- Hagens Berman
Newsfile Corp
1/23
SHAREHOLDER ALERT: Berger Montague Reminds Regeneron Pharmaceuticals (NASDAQ: REGN) Investors of a C...
Newsfile Corp
1/22
REGENERON PHARMACEUTICALS SECURITIES FRAUD NOTICE: Berger Montague Informs Regeneron Pharmaceuticals...
Newsfile Corp
1/21
ROSEN, A LEADING LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Be...
Newsfile Corp
1/21
Faruqi & Faruqi Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit with...
Newsfile Corp
1/20
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secu...
Newsfile Corp
1/19
REGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Regeneron Pharmaceuticals, Inc...
Newsfile Corp
1/18
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Cou...
Newsfile Corp
1/18
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Phar...
Newsfile Corp
1/17
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to S...
Newsfile Corp
1/16
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmac...
Newsfile Corp
1/14
Regeneron Pharmaceuticals, Inc. (REGN) Securities Fraud: Contact Berger Montague To Discuss Your Rig...
Newsfile Corp
1/12
STOCKHOLDER ALERT: Pending Securities Fraud Lawsuit Against Regeneron Pharmaceuticals (REGN)
Newsfile Corp
1/12
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmac...
Newsfile Corp
1/10
REGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Regeneron Pharmaceuticals, Inc...
Newsfile Corp
1/10
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Phar...
GlobeNewswire
8/28/2024
Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference
GlobeNewswire
8/26/2024
Ordspono™ (odronextamab) Approved in the European Union for the Treatment of Relapsed/Refractory Fol...
GlobeNewswire
8/26/2024
Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadersh...
GlobeNewswire
8/21/2024
Regeneron Provides Update on Biologics License Application for Linvoseltamab
GlobeNewswire
8/15/2024
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...